Susan Audino Joins CloudLIMS’ Scientific Advisory Board
CloudLIMS, a Laboratory Information Management company specialized in offering data management solutions for cannabis testing laboratories, today announced that Dr. Susan Audino, Chair, Cannabis Advisory Panel and Chair, Cannabis Working Group at AOAC International, has joined its Scientific Advisory Board, contributing her rich experience in the cannabis industry to the company’s informatics solutions.
Dr. Susan Audino is an A2LA lead assessor and instructor, a laboratory consultant, a board member of the Center for Research on Environmental Medicine in Maryland, and also serves on several expert advisory panels for the cannabis industry. As a specialized consultant, she will provide advice and lend her expertise to improve the company’s cloud-based Laboratory Information Management System (LIMS) to meet regulatory compliance and quality standards for cannabis testing laboratories.
Dr. Susan Audino obtained a Ph.D. degree in Chemistry with an analytical chemistry major, physical and biochemistry minor areas. She currently owns and operates a consulting firm to serve chemical and biological laboratories. Dr. Audino’s interest directly involves cannabis consumer safety and protection, and promotes active research towards the development of official test methods specifically for the cannabis industry, and to advocate appropriate clinical research. In addition to serving on Expert Review Panels, she is chairing the first Cannabis Advisory Panel and the working group with AOAC International. She is a member of the Executive Committee of the ASTM Cannabis Section and has served as a consultant to numerous cannabis laboratories and state regulatory bodies.
"We are extremely pleased that Dr. Susan Audino has agreed to join our Scientific Advisory Board. Her experience in achieving standards in cannabis testing will prove to be a major asset in achieving compliance standards, and offer a more robust Laboratory Information Management System to cannabis testing laboratories", said Arun Apte, CEO at CloudLIMS.
Computer scientists at Carnegie Mellon University say neural networks and supervised machine learning techniques can efficiently characterize cells that have been studied using single cell RNA-sequencing (scRNA-seq). This finding could help researchers identify new cell subtypes and differentiate between healthy and diseased cells.